Transgenomic, Inc. (TBIO) Announces Global Availability of CRC RAScan™ Mutation Detection Test for Use in Patients With Metastatic Colorectal Cancer to Help Identify Appropriate Treatment
5/16/2013 11:30:38 AM
More...
|
Transgenomic, Inc. (TBIO) Reports First Quarter 2013 Financial Results
5/9/2013 7:23:41 AM
More...
|
Reminder: Transgenomic, Inc. (TBIO) to Hold First Quarter Financial Results Conference Call Today
5/8/2013 8:26:01 AM
More...
|
Transgenomic, Inc. (TBIO) Teams Up With Amgen (AMGN) to Develop CE-IVD Test
5/6/2013 7:18:04 AM
More...
|
Transgenomic, Inc. (TBIO) to Hold First Quarter Financial Results Conference Call on May 8, 2013
5/1/2013 9:18:46 AM
More...
|
Governor Presents 2013 Bioscience Award to Transgenomic, Inc. (TBIO) at Bio Nebraska Life Sciences Association Annual Meeting
4/17/2013 10:20:02 AM
More...
|
Transgenomic, Inc. (TBIO) Reports Fourth Quarter and Fiscal Year 2012 Financial Results
3/14/2013 6:23:29 AM
More...
|
Transgenomic, Inc. (TBIO) Announces $8.3 Million Private Placement Financing
1/25/2013 9:02:36 AM
More...
|
Transgenomic, Inc. (TBIO) to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
11/28/2012 9:30:48 AM
More...
|
Transgenomic, Inc. (TBIO) to Hold Third Quarter Financial Results Conference Call Today
11/7/2012 9:43:19 AM
More...
|
|